343 related articles for article (PubMed ID: 26711660)
21. Interactions of copper and copper chelate compounds with the amyloid beta peptide: An investigation into electrochemistry, reactive oxygen species and peptide aggregation.
Crnich E; Lullo R; Tabaka A; Havens MA; Kissel DS
J Inorg Biochem; 2021 Sep; 222():111493. PubMed ID: 34116425
[TBL] [Abstract][Full Text] [Related]
22. New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.
El Khoury Y; Dorlet P; Faller P; Hellwig P
J Phys Chem B; 2011 Dec; 115(49):14812-21. PubMed ID: 22026330
[TBL] [Abstract][Full Text] [Related]
23. Key roles of Tyr 10 in Cu bound Aβ complexes and its relevance to Alzheimer's disease.
Lu N; Li J; Gao Z
Arch Biochem Biophys; 2015 Oct; 584():1-9. PubMed ID: 26247837
[TBL] [Abstract][Full Text] [Related]
24. Copper(I) Chelators for Alzheimer's Disease.
Opare SKA; Rauk A
J Phys Chem B; 2017 Dec; 121(50):11304-11310. PubMed ID: 29172520
[TBL] [Abstract][Full Text] [Related]
25. Effects of oxidation on redox and cytotoxic properties of copper complex of Aβ1-16 peptide.
Ramteke SN; Walke GR; Joshi BN; Rapole S; Kulkarni PP
Free Radic Res; 2014 Dec; 48(12):1417-25. PubMed ID: 25179438
[TBL] [Abstract][Full Text] [Related]
26. An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Young TR; Kirchner A; Wedd AG; Xiao Z
Metallomics; 2014 Mar; 6(3):505-17. PubMed ID: 24493126
[TBL] [Abstract][Full Text] [Related]
27. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
28. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
29. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
30. The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.
Shearer J; Szalai VA
J Am Chem Soc; 2008 Dec; 130(52):17826-35. PubMed ID: 19035781
[TBL] [Abstract][Full Text] [Related]
31. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
[TBL] [Abstract][Full Text] [Related]
32. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?
De Ricco R; Valensin D; Dell'Acqua S; Casella L; Hureau C; Faller P
Chembiochem; 2015 Nov; 16(16):2319-28. PubMed ID: 26338312
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.
Tickler AK; Smith DG; Ciccotosto GD; Tew DJ; Curtain CC; Carrington D; Masters CL; Bush AI; Cherny RA; Cappai R; Wade JD; Barnham KJ
J Biol Chem; 2005 Apr; 280(14):13355-63. PubMed ID: 15668252
[TBL] [Abstract][Full Text] [Related]
34. Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease.
Raffa DF; Gómez-Balderas R; Brunelle P; Rickard GA; Rauk A
J Biol Inorg Chem; 2005 Dec; 10(8):887-902. PubMed ID: 16267663
[TBL] [Abstract][Full Text] [Related]
35. How Do Metalloproteins Tame the Fenton Reaction and Utilize •OH Radicals in Constructive Manners?
Wang B; Zhang X; Fang W; Rovira C; Shaik S
Acc Chem Res; 2022 Aug; 55(16):2280-2290. PubMed ID: 35926175
[TBL] [Abstract][Full Text] [Related]
36. Copper binding and redox chemistry of the Aβ16 peptide and its variants: insights into determinants of copper-dependent reactivity.
Yako N; Young TR; Cottam Jones JM; Hutton CA; Wedd AG; Xiao Z
Metallomics; 2017 Mar; 9(3):278-291. PubMed ID: 28145544
[TBL] [Abstract][Full Text] [Related]
37. Amine oxidative N-dealkylation via cupric hydroperoxide Cu-OOH homolytic cleavage followed by site-specific fenton chemistry.
Kim S; Ginsbach JW; Lee JY; Peterson RL; Liu JJ; Siegler MA; Sarjeant AA; Solomon EI; Karlin KD
J Am Chem Soc; 2015 Mar; 137(8):2867-74. PubMed ID: 25706825
[TBL] [Abstract][Full Text] [Related]
38. Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-beta complexes.
Hureau C; Balland V; Coppel Y; Solari PL; Fonda E; Faller P
J Biol Inorg Chem; 2009 Sep; 14(7):995-1000. PubMed ID: 19618220
[TBL] [Abstract][Full Text] [Related]
39. ESEEM analysis of multi-histidine Cu(II)-coordination in model complexes, peptides, and amyloid-β.
Silva KI; Michael BC; Geib SJ; Saxena S
J Phys Chem B; 2014 Jul; 118(30):8935-44. PubMed ID: 25014537
[TBL] [Abstract][Full Text] [Related]
40. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
